Skip to main content
SpringerLink
Log in

Association of Sleep Apnea Severity and Obesity with Insulin Resistance, C-Reactive Protein, and Leptin Levels in Male Patients with Obstructive Sleep Apnea

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Obesity is the major confounding factor in the relationship between obstructive sleep apnea and increased risk for cardiovascular disease. The aim of the study was to investigate the association of sleep apnea severity with insulin resistance, leptin, and CRP levels in a cohort of male patients. Sixty-seven men referred to our sleep laboratory for evaluation of suspected obstructive sleep apnea syndrome (OSAS) were divided into three groups according to apnea severity: non-OSAS group (n = 15), mild to moderate OSAS group (n = 26), and severe OSAS (n = 26). Insulin resistance was estimated by the homeostasis model assessment method. HOMA values were similar in the three groups: (3.2 ± 2.2 vs. 3.3 ± 1.8 vs. 3.6 ± 1.5, respectively, p = 0.71). Leptin levels were higher in the mild to moderate OSAS group (23.1 ± 21.8 ng/ml, p < 0.05) and in the severe OSAS group (20.2 ± 17.5 ng/ml, p < 0.05) than in the non-OSAS group (9.4 ± 6.4 ng/ml). CRP levels were significantly higher in severe sleep apnea (0.35 ± 0.3 vs. 0.19 ± 0.1 mg/dl, p < 0.05). In multiple regression analyses, waist-to-hip ratio (WHR) was the most significant determinant of HOMA estimation for insulin resistance. WHR and the percentage of total sleep time spent with hypoxemia (%TST with SaO2 <90%) were significant predictors for leptin levels, while body mass index (BMI) and the %TST with SaO2 <90% were the best predicting parameters for CRP levels. Insulin resistance estimated by the HOMA method in male patients with OSAS was not associated with sleep apnea severity independent of obesity. The severity of nocturnal hypoxemia was associated with leptin and CRP levels independent of obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829–1836

    Article  CAS  PubMed  Google Scholar 

  2. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O’Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25

    Article  CAS  PubMed  Google Scholar 

  3. He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94:9–14

    Article  CAS  PubMed  Google Scholar 

  4. Fletcher EC (1996) Obstuctive sleep apnea and cardiovascular disease. Monaldi Arch Chest Dis 51:77–80

    CAS  PubMed  Google Scholar 

  5. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530

    Article  PubMed  Google Scholar 

  6. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin levels and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829–839

    Article  PubMed  Google Scholar 

  7. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46:801–809

    Article  CAS  PubMed  Google Scholar 

  8. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607

    Article  CAS  PubMed  Google Scholar 

  9. Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM, Wagenknecht L (2004) Predictors of the incident metabolic syndrome in adults. The insulin resistance atherosclerosis study. Diabetes Care 27:788–793

    Article  PubMed  Google Scholar 

  10. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee (2003) Waist circumference, waist to hip ratio, and body mass index and their correlation with cardiovascular disease risk in Australian adults. J Intern Med 254:555–563

    Article  CAS  PubMed  Google Scholar 

  11. Klein S, Coppack SW, Mohamed-Ali V, Landt M (1996) Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45:984–987

    Article  CAS  PubMed  Google Scholar 

  12. Schwartz MW, Seeley RJ (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. N Eng J Med 336:1803–1811

    Article  Google Scholar 

  13. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF (1996) Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Eng J Med 334(5):292–295

    Article  CAS  Google Scholar 

  14. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996) Leptin: the tale of an obesity gene. Diabetes 45:1455–1462

    Article  CAS  PubMed  Google Scholar 

  15. Mark AL, Correia ML, Rahmouni K, Haynes WG (2002) Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20:1245–1250

    Article  CAS  PubMed  Google Scholar 

  16. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–3056

    Article  CAS  PubMed  Google Scholar 

  17. Correia ML, Rahmouni K (2006) Role of leptin in the cardiovascular and endocrine complications of the metabolic syndrome. Diabetes Obes Metab 8:603–610

    Article  CAS  PubMed  Google Scholar 

  18. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135

    Article  CAS  PubMed  Google Scholar 

  19. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199–204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143

    Article  CAS  PubMed  Google Scholar 

  21. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE (1998) “Syndrome Z’’: the interaction of sleep apnea, vascular risk factors and heart disease. Thorax 53:S25-S28

    Article  PubMed  PubMed Central  Google Scholar 

  22. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J (1993) Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 17:533–540

    CAS  PubMed  Google Scholar 

  23. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Eng J Med 342:1378–1384

    Article  CAS  Google Scholar 

  24. Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382

    Article  CAS  PubMed  Google Scholar 

  25. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB (2002) Snoring as a risk factor of type II diabetes mellitus: a prospective study. Am J Epidemiol 155:387–392

    Article  PubMed  Google Scholar 

  26. Gami AS, Caples SM, Somers VK (2003) Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32(4):869–894

    Article  PubMed  Google Scholar 

  27. Ip MSM, Lam B, Ng MMT, Lam WK, Tsant KWT, Lam KSL (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676

    Article  PubMed  Google Scholar 

  28. Punjabi NM, Sorkin JD, Katzel L, Goldberg A, Schwartz A, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle aged and overweight men. Am J Respir Crit Care Med 165:677–682

    Article  PubMed  Google Scholar 

  29. Tassone F, Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Grottoli S, Gai V, Ghigo E, Maccario M (2003) Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol (Oxf) 59:374–379

    Article  Google Scholar 

  30. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea, daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158

    Article  CAS  PubMed  Google Scholar 

  31. McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195

    Article  CAS  PubMed  Google Scholar 

  32. Peled N, Kassirer M, Shitrit D, Kogan Y, Shlomi D, Berliner AS, Kramer MR (2007) The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 101:1696–1701

    Article  PubMed  Google Scholar 

  33. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK (2000) Increases in leptin levels, sympathetic drive and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:H234–H237

    CAS  PubMed  Google Scholar 

  34. Ip MS, Lam KS, Ho C, Tseng KW, Lam W (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118:580–586

    Article  CAS  PubMed  Google Scholar 

  35. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712

    Article  CAS  PubMed  Google Scholar 

  36. Ozturk L, Murat U, Tamer L, Celicoglu F (2003) The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 129:538–540

    Article  PubMed  Google Scholar 

  37. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464

    Article  CAS  PubMed  Google Scholar 

  38. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134

    Article  CAS  PubMed  Google Scholar 

  39. Punjabi NM, Beamer BA (2007) C-reactive protein is associated with sleep disordered breathing independent of obesity. Sleep 30:29–34

    Article  PubMed  Google Scholar 

  40. Stoohs RA, Facchini F, Guilleminault C (1996) Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154:170–174

    Article  CAS  PubMed  Google Scholar 

  41. Davies RJO, Turner R, Crosby J, Stradling JR (1994) Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 3:180–185

    Article  CAS  PubMed  Google Scholar 

  42. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741

    Article  PubMed  Google Scholar 

  43. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22–27

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Sharma SK, Kumpawat S, Coel A, Banga A, Ramakrishnan L, Chaturvedi P (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8:12–17

    Article  CAS  PubMed  Google Scholar 

  45. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin levels and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829–839

    Article  PubMed  Google Scholar 

  46. Sanner BM, Kollhoser P, Buechner N, Zidek W, Tepel M (2004) Influence of treatment on leptin levels in patients with obstructive sleep apnea. Eur Respir J 23:601–604

    Article  CAS  PubMed  Google Scholar 

  47. Barcelo A, Barbe F, Llompart E, de la Pena M, Duran-Cantolla J, Ladaria A, Bosch M, Guerra L, Agusti AG (2005) Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171:183–187

    Article  PubMed  Google Scholar 

  48. Harsch I, Konturek P, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257

    Article  CAS  PubMed  Google Scholar 

  49. Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27:1507–1511

    Article  PubMed  Google Scholar 

  50. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovasular risk markers in obstructive sleep apnoea and correlation with obesity. Thorax 62:509–514

    Article  PubMed  PubMed Central  Google Scholar 

  51. Chung S, Yoon IY, Shin YK, Lee CH, Kim JW, Lee T, Choi DJ, Ahn HJ (2007) Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea. Sleep 30:997–1001

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R (2003) Abdominal obesity, insulin resistance and metabolic syndrome in a southern European population. Eur J Intern Med 14:101–106

    Article  CAS  PubMed  Google Scholar 

  53. Kaditis A, Alexopoulos E, Damani E, Karadonta I, Kostadima E, Tsolakidou A, Gourgoulianis K, Syrogiannopoulou GA (2005) Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol 40:515–523

    Article  PubMed  Google Scholar 

  54. Tauman R, O’Brien L, Ivanenko A, Gozal D (2005) Obesity rather than sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 116:e66–e73

    Article  PubMed  Google Scholar 

  55. Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 3:467–472

    PubMed  PubMed Central  Google Scholar 

  56. Hatipoğlu U, Rubinstein I (2003) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70:665–671

    Article  PubMed  Google Scholar 

  57. Luo JD, Zhang GS, Chen MS (2005) Leptin and cardiovascular disease. Drug News Perspect 18:427–431

    Article  CAS  PubMed  Google Scholar 

  58. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T (2005) Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea–hypopnea syndrome. Chest 127:716–721

    Article  PubMed  Google Scholar 

  59. Bhakdi S, Torzewski M, Klouche M, Hemmes M (1999) Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 19:2348–2354

    Article  CAS  PubMed  Google Scholar 

  60. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534

    Article  CAS  PubMed  Google Scholar 

  61. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J (2000) C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20:2094–2099

    Article  CAS  PubMed  Google Scholar 

  62. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990) Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179–1186

    Article  CAS  PubMed  Google Scholar 

  63. Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51

    Article  PubMed  Google Scholar 

  64. Polotsky V, Li J, Punjabi N, Rubin AE, Smith PL, Schwartz AR, O’Donnell CP (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Wisse BE (2004) The inflammatory syndrome: the role of adipose cytokines in metabolic disorders liked to obesity. J Am Soc Nephrol 15:2792–2800

    Article  CAS  PubMed  Google Scholar 

  66. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L (1997) Leptin selectively decreases visceral obesity and enhances insulin sensitivity. J Clin Invest 100:3105–3110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Lichnovská R, Gwozdziewiczová S, Chlup R, Hrebicek J (2005) Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Papers 149:119–126

    Article  Google Scholar 

  68. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary Medicine, Sleep Laboratory, Henry Dunant Hospital, 107 Mesogeion Avenue, Athens, Greece

    Fotis Kapsimalis & George Varouchakis

  2. Department of Clinical Biochemistry, Henry Dunant Hospital, Athens, Greece

    Asimina Manousaki, Spiros Daskas & Dimitra Nikita

  3. Sleep Medicine, Research and Education, Gaylord Hospital, Wallingford, Connecticut, 06492, USA

    Meir Kryger

  4. Department of Pulmonary Medicine, Medical School, University of Thessaly, Larissa, Greece

    Konstantinos Gourgoulianis

Authors
  1. Fotis Kapsimalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Varouchakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Asimina Manousaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Spiros Daskas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dimitra Nikita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Meir Kryger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Konstantinos Gourgoulianis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fotis Kapsimalis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapsimalis, F., Varouchakis, G., Manousaki, A. et al. Association of Sleep Apnea Severity and Obesity with Insulin Resistance, C-Reactive Protein, and Leptin Levels in Male Patients with Obstructive Sleep Apnea. Lung 186, 209–217 (2008). https://doi.org/10.1007/s00408-008-9082-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-008-9082-x

Keywords

Search

Navigation